4 Cities for Assessing CAlcification PRognostic Impact After TAVI

CompletedOBSERVATIONAL
Enrollment

1,600

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions
Heart Disease
Interventions
DEVICE

Transcatheter Aortic Valve Implantation (TAVI)

"TAVI is a well-accepted method for aortic valve replacement without surgery. It is currently proposed to patients at high surgical risk or contraindicated to surgery. It consists of introducing a valve inserted inside a stent by the femoral artery in most cases.~Aortic calcifications will be determined by the analysis of the CT-scan performed systematically before the procedure. A semi-automated software (CreaTools) will be used"

Trial Locations (1)

69004

Hôpital de la Croix Rousse, Lyon

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT02935491 - 4 Cities for Assessing CAlcification PRognostic Impact After TAVI | Biotech Hunter | Biotech Hunter